Interstitial Pneumonia

Interstitial Pneumonia

What is the meaning of interstitial pneumonia?
interstitial pneumonia:  chronic lung disease affecting the interstitial tissue of the lungs.

What is interstitial pneumonia/interstitial thickening?
Interstitial lung disease is a term used to refer to a particular type of inflammation of the interstitium of the lungs.

What does interstitial pneumonia mean?
1. chronic lung disease affecting the interstitial tissue of the lungs
Interstitial pneumonia is a disease in which the mesh-like walls of the alveoli become inflamed.  The pleura (a thin covering that protects and cushions the lungs ).

Interstitial pneumonia ( NSIP) is a rare disorder that affects the tissue that surrounds and separates the

Interstitial pneumonia

noun chronic lung disease affecting the interstitial tissue of the lungs.
Interstitial pneumonia:  Another name for Interstitial lung disease (or close medical condition association).

Interstitial pneumonia:  Related Diseases
Interstitial pneumonia:  Interstitial pneumonia is listed as a type of (or associated with) the following medical conditions in our database:

  • Respiratory conditions
  • Lung conditions
  • Pneumonia
  • Chest conditions

Causes of Interstitial pneumonia

Some of the causes of Interstitial pneumonia are included in the list below:

  • Pulmonary fibrosis
  • Lymphocytic interstitial pneumonia
  • Desquamative interstitial pneumonitis
  • Coin lesion (chest x-ray)
  • Pneumonia

Symptoms of Interstitial pneumonia (Interstitial lung disease)

Some of the symptoms of Interstitial pneumonia include:

  • Fever
  • Fatigue
  • Muscle pain
  • Joint pain
  • Abnormal chest sounds

These medical disease topics may be related to Interstitial pneumonia:

  • idiopathic pulmonary fibrosis
  • restrictive lung disease
  • idiopathic fibrosing alveolitis

Terms associated with Interstitial pneumonia:
Broader terms for Interstitial pneumonia

  • respiratory disease
  • respiratory illness
  • respiratory disorder

Hierarchical classifications of Interstitial pneumonia

The following list attempts to classify Interstitial pneumonia into categories where each line is a subset of the next.

  • respiratory disease,respiratory disorder,respiratory illness
  • disease
  • illness,malady,sickness,unwellness
  • health problem,ill health,unhealthiness
  • pathological state
  • condition,status

Interstitial lung disease/ Interstitial pneumonia

Description of Interstitial pneumonia
Interstitial pneumonia (medical condition):  A category of chronic lung diseases characterized by scarring and/or inflammation of the lungs.
Interstitial pneumonia:  chronic lung disease affecting the interstitial tissue of the lungs.


Interstitial pneumonias are a confusing and frustrating set of diseases both for the treating physician and for the diagnostic pathologist.  One source of the confusion has been the lack of overlapping terms that treating physicians and pathologists use.  For example, idiopathic pulmonary fibrosis (IPF) is a clinical term describing a slowly progressive, chronic interstitial pneumonia.  Since many of the interstitial pneumonias, including UIP, DIP, and NSIP, fall under this category, it is a non-specific term.  Most pathologists who are experts in lung pathology use the terms IPF and UIP to mean the same disease process.  To complicate matters even further, European clinicians utilize the term cryptogenic fibrosing alveolitis for IPF. Pathologists also share in the confusion.  Terms that were commonly used by pathologists just a few years ago have also undergone an evolution.  Bronchiolitis obliterans with organizing pneunomina (BOOP) is no longer used because it has been considered a mixture of terms.  Lymphocytic interstitial pneumonia (LIP) is now considered a lymphoproliferative disease.  Giant cell interstitial pneumonitis (GIP) is now considered a hard metal pneumoconiosis.

The symptoms vary for each of the pneumonias but most are characterized by a slowly progressive shortness of breath.  Chest radiographs reveal a hazy ground glass appearance with linear opacities.  Most of the diseases are progressive and are treated with corticosteroids.

Usual interstitial pneumonia (UIP) is a form of lung disease characterized by progressive scarring of both lungs.   The scarring (fibrosis) involves the supporting framework (interstitium) of the lung.  UIP is thus classified as a form of interstitial lung disease.  The term "usual" refers to the fact that UIP is the most common form of interstitial fibrosis.  "Pneumonia" indicates "lung abnormality", which includes fibrosis and inflammation.  The term used for UIP in the British literature is cryptogenic fibrosing alveolitis, a term that has fallen out of favor since the basic underlying pathology is now thought to be fibrosis, not inflammation.


The cause of the scarring in UIP may be known or unknown.  The latter situation is more common.  Since the medical term for conditions of unknown cause is "idiopathic"  the clinical term for UIP of unknown cause is idiopathic pulmonary fibrosis (IPF).  Examples of known causes of UIP include systemic sclerosis/scleroderma, rheumatoid arthritis, asbestosis and chronic nitrofurantoin toxicity.


The typical symptoms of UIP are progressive shortness of breath and cough for a period of months.  In some patients, UIP is diagnosed only when a more acute disease supervenes and brings the patient to medical attention.


Regardless of etiology, UIP is relentlessly progressive, usually leading to respiratory failure and death.  Some patients do well for a prolonged period of time, but then deteriorate rapidly because of a superimposed acute illness (so-called "accelerated UIP").  The outlook for long-term survival is poor.  In most studies, the median survival is 3 to 4 years.  Patients with UIP in the setting of rheumatoid arthritis have a slightly better prognosis than UIP without a known cause (IPF).

How is interstitial lung disease treated?

The choice of treatment depends upon a number of factors including the cause of the interstitial lung disease and the overall health status of the patient.  Most commonly, corticosteroid drugs are given in an attempt to reduce the inflammation.  Sometimes, immune-suppressing drugs, such as asazathioprine (Imuran) or cyclophosphamide(Cytoxan) are also given, either in combination with steroids or following a course of steroid treatment.  Some patients with interstitial lung disease benefit from oxygen therapy and/or respiratory therapy (pulmonary rehabilitation) to improve daily functioning.  Smoking cessation is critical for those with interstitial lung disease.  Finally, in severe cases, lung transplantation may be considered in certain patients.


What is pneumonia?   Pneumonia is an infection of the tiny air sacs of the lungs.  There are many different types of pneumonia, which can range from mild to severe.

The symptoms vary for each of the pneumonias but most are characterized by a slowly progressive shortness of breath.  Chest radiographs reveal a hazy ground glass appearance with linear opacities.  Most of the diseases are progressive and are treated with corticosteroids.

An incurable, deadly lung disorder.

Medical Marijuana

Medical marijuana should never be smoked by anyone with lung problems.  My suggestion is that you acquire a Sativa x Indica hybrid and then make yourself a whole plant tincture.  Place a drop under the tongue twice a day to start.  Increase when necessary.

I also recommend edibles made from  good cannabutter.  These you should also make yourself using:  leaves, petioles, and (bud) shake/ trimmings and unsalted butter.  Or if making an oil:  use good quality olive oil, grapeseed oil, etc.

There are articles on our website:  Acquire organically grown medical marijuana (free of any pathogens).  Make your own whole plant extracts.  This way you will be taking the best medicine possible.  (you can heat the medical marijuana in your oven--302 degrees for five minutes) to kill any:  microorganisms, mold (mould), fungus or spores.

  • tinctures
  • how to make cannabutter
  • how to make cannabis oil


1. Travis WD, King TE, Bateman ED, et al. (2002). "ATS/ERS international multidisciplinary consensus classification of idiopathic interstitial pneumonias. General principles and recommendations.". American Journal of Respiratory and Critical Care Medicine 165 (5): 277–304.PMID 11790668.
2. Sumikawa H, et al (2008). "Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival.". American Journal of Respiratory and Critical Care Medicine 177 (4): 433–439. doi:10.1164/rccm.200611-1696OC. PMID 17975197.
3. Katzenstein AL, Mukhopadhyay S, Myers JL (2008). "Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases.". Human Pathology 39 (9): 1275–1294. doi:10.1016/j.humpath.2008.05.009. PMID 18706349.
4. Leslie, Kevin O; Wick, Mark R. (2005). Practical pulmonary pathology: a diagnostic approach. Edinburgh: Churchill Livingstone. ISBN 0-443-06631-0. OCLC 156861539.
5. Averill Abraham Liebow at Who Named It?
Coalition for Pulmonary Fibrosis: Pulmonary Fibrosis Patient Services, Education; Funding Research to Find a Cure for PF -
PA-IPF - The Pennsylvania Idiopathic Pulmonary Fibrosis State Registry at University of Pittsburgh

Traffic Roots Pixel